Danaher Corporation vs Stitch Fix Inc — how do they compare? Danaher Corporation trades at $219.58 (market cap $152.87B), while Stitch Fix Inc trades at $2.78 (market cap $366.07M). The key difference: Danaher Corporation is far larger — about 417.6× Stitch Fix Inc's market cap, and Danaher Corporation pays a 0.74% dividend while Stitch Fix Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Danaher Corporation for 69 Days and Stitch Fix Inc for 31 Days on average.
| DHR | SFIX | |
|---|---|---|
Market Cap | $152.87B | $366.07M |
Volume | 5,228,698 | 5,152,008 |
Sector | Health | Consumer Cyclical |
52-Week High | $242.05 | $5.64 |
52-Week Low | $161.91 | $2.16 |
Typical Hold Time | 69 Days | 31 Days |
Enterprise Value | $175.08B | $261.88M |
Dividend Yield | 0.74% | — |
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $218.49, up 1.36% on the day, with a bullish technical signal and consistent earnings beats in recent quarters. The stock shows strong profitability with a 58.51% gross margin and 15.95% net income margin, though revenue growth has been modest. Analyst consensus is strongly bullish with a $230.31 price target, supported by institutional buying activity and a recent dividend announcement.
The outlook for DHR is positive, driven by earnings momentum and institutional confidence, but risks include elevated valuation multiples and competitive pressures in the healthcare sector. Investors should weigh the strong analyst support against potential margin compression and macroeconomic headwinds affecting capital spending.
Stitch Fix (SFIX) trades at $2.775, up 1.65% on the day, but faces a bearish technical outlook with recent earnings beats overshadowed by weak forward guidance. The company reported a net loss of $28.74 million for 2025, though losses have narrowed significantly from prior years. Revenue remains stable at $1.27 billion, but negative cash flow and multiple law firm investigations into potential fraud create headwinds.
The investment outlook is cautious. While valuation appears cheap on a P/S basis and AI initiatives show promise, declining active clients, negative profitability metrics, and bearish analyst sentiment limit upside. The primary risk is execution against a challenging consumer backdrop, with the stock's trajectory hinging on a sustainable turnaround in client growth and margins.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →Stitch Fix Inc offers personal style service for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandises with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types and price points including Women's, Petite, Maternity, Men's and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry and handbags, and sells merchandise across various range of price points.
Read more on SFIX →